Am. J. Respir. Crit. Care Med., Volume 162, Number 5, November 2000, 1622-1626

Geographic Distribution of Human Immunodeficiency Virus-associated Pneumocystis carinii Pneumonia in San Francisco

ALISON M. MORRIS, MELINDA SWANSON, HUAN HA, and LAURENCE HUANG

Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California

The epidemiology of Pneumocystis carinii pneumonia (PCP) and its geographic distribution are incompletely understood. We examined the influence of geographic location as a risk factor for PCP through a retrospective case-control study of HIV-infected persons evaluated for PCP at San Francisco General Hospital. Subjects had microscopically confirmed PCP diagnosed between January 1996 and June 1999. Control subjects had a presentation suggestive of PCP, but had bronchoalveolar lavage examination that did not reveal P. carinii. Medical chart review was performed to obtain demographic and clinical characteristics of the subjects as well as their addresses at time of PCP evaluation. Multivariate analyses were performed in order to identify variables associated with PCP. Lack of P. carinii prophylaxis and a CD4 cell count  50 cells/µl were independent predictors of an increased risk of PCP. Interestingly, subjects living in the 94103 zip code had a significantly lower risk of PCP than subjects in other areas (odds ratio = 0.2, 95% confidence interval 0.1-0.6, p < 0.01). This effect was present despite controlling for risk factors for PCP such as use of prophylaxis or antiretroviral therapy, CD4 cell count, and HIV RNA level. We conclude that residence in the 94103 zip code of San Francisco is associated with a substantially lower risk of PCP than residence in other areas of the city.

This article has been cited by other articles:

				A. F. Freeman, J. Davis, V. L. Anderson, W. Barson, D. N. Darnell, J. M. Puck, and S. M. Holland Pneumocystis jiroveci Infection in Patients With Hyper-Immunoglobulin E Syndrome Pediatrics, October 1, 2006; 118(4): e1271 - e1275. [Abstract] [Full Text] [PDF]

				R F Miller, A R Lindley, A Copas, H E Ambrose, R J O Davies, and A E Wakefield Genotypic variation in Pneumocystis jirovecii isolates in Britain Thorax, August 1, 2005; 60(8): 679 - 682. [Abstract] [Full Text] [PDF]

				R. F. Miller, A. R. Lindley, H. E. Ambrose, A. S. Malin, and A. E. Wakefield Genotypes of Pneumocystis jiroveci Isolates Obtained in Harare, Zimbabwe, and London, United Kingdom Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3979 - 3981. [Abstract] [Full Text] [PDF]

				P. S. Arno, M. N. Gourevitch, E. Drucker, J. Fang, C. Goldberg, M. Memmott, K. Bonuck, N. Deb, and E. Schoenbaum Analysis of a Population-Based Pneumocystis carinii Pneumonia Index as an Outcome Measure of Access and Quality of Care for the Treatment of HIV Disease Am J Public Health, March 1, 2002; 92(3): 395 - 398. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				R. F. Miller, H. E. Ambrose, and A. E. Wakefield Pneumocystis carinii f. sp. hominis DNA in Immunocompetent Health Care Workers in Contact with Patients with P. carinii Pneumonia J. Clin. Microbiol., November 1, 2001; 39(11): 3877 - 3882. [Abstract] [Full Text] [PDF]

				Geographic Clustering of PCP AIDS Clinical Care, February 1, 2001; 2001(201): 5 - 5. [Full Text]

				J. M. Beck Pneumocystis carinii and Geographic Clustering . Evidence for Transmission of Infection Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1605 - 1606. [Full Text]